Skip to main content
Venus Remedies Ltd. logo

Venus Remedies Ltd. — Investor Relations & Filings

Ticker · VENUSREM ISIN · INE411B01019 LEI · 335800PBHMB6GQMFN127 BSE.NS Manufacturing
Open in API
Filings indexed 620 across all filing types
Latest filing 2024-10-29 Regulatory Filings
Country IN India
Listing BSE.NS VENUSREM

About Venus Remedies Ltd.

https://venusremedies.com/

Venus Remedies Ltd. is a research-driven organization specializing in the development and manufacturing of innovative pharmaceutical formulations. The company focuses on critical therapeutic segments, including antimicrobial resistance, oncology, neurology, orthopedics, and pain management. It operates advanced manufacturing facilities and maintains a dedicated research and development wing, the Venus Medicine Research Centre, which prioritizes the creation of novel drug delivery systems and solutions for multi-drug resistant infections. Its product portfolio features a diverse range of injectables and specialized treatments, such as Elores, aimed at addressing complex clinical needs. The company serves a global market, providing healthcare solutions through a commitment to scientific excellence and international regulatory standards.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2024-10-29 English
Outcome of Board Meeting
Regulatory Filings
2024-10-29 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (70 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or regulatory filing details. Given the lack of content, this document does not fit any specific report category and defaults to the fallback category for miscellaneous filings.
2024-10-18 English
Board Meeting — VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for th…
Regulatory Filings
2024-10-18 English
Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (276 characters) and contains no substantive content other than a digital signature and omitted images. There is no financial data, report content, or detailed information. It does not contain any report or announcement text. Given the lack of content and the presence of a digital signature, this is likely a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2024-10-08 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document text is extremely short (66 characters) and contains only a digital signature with no substantive content or financial data. It does not contain any report, announcement, or detailed information. Given the lack of content, it cannot be classified as any specific report or announcement type. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2024-10-05 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.